Albuterol inhalers [12]

New England Journal of Medicine

Volumn 356, Issue 26, 2007, Pages 2749-

  Gross, Nicholas J ^a  

^a LOYOLA UNIVERSITY CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; CHLOROFLUOROCARBON; FLUORINATED HYDROCARBON; ORCIPRENALINE; PROPELLANT; SALBUTAMOL; GENERIC DRUG;

DRUG COST; DRUG INDUSTRY; DRUG MARKETING; FOOD AND DRUG ADMINISTRATION; HUMAN; LETTER; METERED DOSE INHALER; PRIORITY JOURNAL; RESPIRATORY TRACT DISEASE; ASTHMA; ECONOMICS; FEE; NOTE; UNITED STATES;

AEROSOL PROPELLANTS; ALBUTEROL; ASTHMA; CHLOROFLUOROCARBONS; DRUGS, GENERIC; FEES, PHARMACEUTICAL; HUMANS; HYDROCARBONS, FLUORINATED; METERED DOSE INHALERS; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 34347250512     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc070909     Document Type: Letter

References (3)

1. Hendeles L, Colice GL, Meyer RJ. Withdrawal of albuterol inhalers containing chlorofluorocarbon propellants. N Engl J Med 2007;356:1344-51.
2. Food and Drug Administration. Use of ozone-depleting substances: removal of essential use designations; final rule. Fed Regist 2005;70(63):17167-92.
3. United Nations Environment Programme home page. (Accessed June 7, 2007, at http://unep.org.)